Tag:
South Korea
Latest Headlines
Latest Headlines
CEO of J&J OTC unit in Korea faces criminal action over plant foul-up
Problems at a Janssen over-the-counter plant in Korea have gone from unfortunate to very serious now that authorities there intend to pursue criminal charges. This tack means Kim Oak-yeon, CEO of the Johnson & Johnson ($JNJ) subsidiary in South Korea, faces up to three years in jail if convicted.
Life Tech snags Korean reagents outfit amid bidding war
Life Technologies is fielding buyout offers from a competitor and a group of private equity giants, but that hasn't stopped the company from making acquisitions of its own, now snatching up a Korean distributor of reagents and lab instruments.
South Korea's Dong-A, dozens of doctors caught up in kickback probe
In what has been termed the worst pharmaceutical kickback scandal in years, 7 former and current executives of Korea's largest drugmaker, Dong-A Pharmaceutical, have been indicted for paying 4.8 billion won ($4.4 million) in kickbacks
Teva taps S. Korea's Handok for assault on $14B market
Last week, Teva CEO Jeremy Levin promised that his company would conquer new markets around the globe. Now, Teva says it's taking its first step toward expanding in Asia.
Cheap Dx spots lung cancer mutation ripe for Pfizer drug
Personalized medicine takes another step forward, as scientists from Pfizer and South Korea make progress developing a diagnostic test that can quickly and cheaply identify patients who can benefit from the company's lung cancer drug Xalkori (crizotinib).
Sigma-Aldrich gets foothold in S. Korea with API deal
Sigma-Aldrich is tapping the South Korean market with a deal to provide development support for active pharmaceutical ingredients for new non-steroidal anti-inflammatory drugs from a South Korean company.
Korean group enlists WCCT to spur drug development
The Korea Drug Development Fund has recruited another CRO to help kick-start drug development in South Korea, signing a deal with WCCT Global to help local producers get products into the U.S.
Icon partners with Korean CRO group
South Korea has long been touting itself as a go-to destination for clinical trials, and Icon would seem to agree, partnering with the Korea National Enterprise for Clinical Trials.
South Korea's SK Telecom dives into China's medtech industry
In a bid to diversify its portfolio, SK will become the second-largest shareholder of China's Xi'an Tianlong Science and Technology Co.
Catalent targets South Korea with CTC Bio partnership
Catalent Pharma Solutions has teamed up with South Korea's CTC Bio to attract clients looking to market solid oral dose and controlled-release products in the U.S. and Europe.
